PIA
VRTX icon

Perennial Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Perennial Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$48.5K – 501
2025
Q1 		$48.5K Buy
+100
New +$46.6K 0.01% 426

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Perennial Investment Advisors's VRTX Position: Q1 2026 in Review

Perennial Investment Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.5% in Q1 2026, buying an estimated $15.9K and bringing the position to 1,393 shares worth $622K. The position accounts for 0.05% of the portfolio, ranked #260.

Perennial Investment Advisors first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. 1,692 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Perennial Investment Advisors held 1,393 shares of Vertex Pharmaceuticals worth $622K as of Q1 2026.
  • Perennial Investment Advisors bought 34 Vertex Pharmaceuticals shares in Q1 2026, an estimated $15.9K.
  • Vertex Pharmaceuticals made up 0.05% of Perennial Investment Advisors's portfolio in Q1 2026, its #260 holding.
  • Perennial Investment Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.